Skip to content

Pulmonary Hypertension in the Intensive Care Unit (ICU) - Swiss Survey 1

A prospective multicentre study to investigate the prevalence, causes, diagnostic and therapeutic approach of pulmonary hypertension in the Intensive Care Unit (ICU)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN01751283
Enrollment
1000
Registered
2010-10-28
Start date
2009-09-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary hypertension Circulatory System Hypertension

Interventions

The current characteristics, local facilities, diagnostic and therapeutic attitude against PH of the participating ICUs are assessed prior to study beginning by a questionnaire (hospital form). Duri

Sponsors

Swiss Society of Pulmonary Hypertension (Switzerland)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All consecutive patients (no age limit or gender restrictions) admitted to ICU for any reason

Exclusion criteria

Exclusion criteria: Does not meet inclusion criteria

Design outcomes

Primary

MeasureTime frame
Prevalence of PH of any cause in the setting of surgical, medical or interdisciplinary ICUs. During the planned study period of 2 weeks enrolment of about 1000 patients is expected. It is a cross-sectional survey, only follow-up is 30 day mortality.

Secondary

MeasureTime frame
1. Causes of PH in the ICU setting 2. Diagnostic and therapeutic approach to PH by Swiss ICU physicians 3. 30 day outcome of patients admitted to ICU with suspected or confirmed PH During the planned study period of 2 weeks enrolment of about 1000 patients is expected. It is a cross-sectional survey, only follow-up is 30 day mortality.

Countries

Switzerland

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026